Daré Bioscience Amends Bylaws to Lower Shareholder Quorum

What Happened

• Daré Bioscience, Inc. announced on Sept. 10, 2026 that its board approved an amendment to the company’s Third Amended and Restated By‑Laws, effective immediately, reducing the quorum requirement for all stockholder meetings.
• The quorum requirement was changed from "the holders of a majority in voting power of the shares ... entitled to vote" to "the holders of at least one‑third of the voting power of the shares ... entitled to vote."
• The filing (Form 8‑K) was submitted on Sept. 11, 2026 and includes the full text of the bylaw amendment as Exhibit 3.1. The report was signed by Sabrina Martucci Johnson, President and CEO.

Key Details

• Date board approved amendment: September 10, 2026.
• New quorum threshold: at least one‑third (1/3) of voting power (previously a majority).
• Amendment documented in Exhibit 3.1 to the Form 8‑K filed Sept. 11, 2026.
• Report signed by Sabrina Martucci Johnson (President & CEO).

Why It Matters

• A quorum is the minimum share voting power required to conduct a valid stockholder meeting. Changing the threshold from a majority to one‑third formally lowers the minimum participation needed for meetings to proceed.
• For investors, this is a governance change that alters how easily the company can convene meetings and transact shareholder business under its bylaws. The filing provides the official text of the amendment for review.